BPA is one of the highest-volume industrial chemicals on the planet and the building block of polycarbonate plastics and epoxy resins. It lines food and beverage cans, coats water pipes, and forms part of thermal paper receipts, which means human exposure is effectively continuous. The concern is not acute poisoning but endocrine disruption: BPA mimics estrogenic hormones at very low concentrations, and systematic reviews have linked chronic exposure to metabolic disorders, reproductive dysfunction and other health effects. In 2023, the European Food Safety Authority re-evaluated the risks of BPA in foodstuffs and dramatically tightened its tolerable daily intake, underscoring how seriously regulators now treat this ubiquitous compound. Because BPA leaches from containers and products into water systems, environmental monitoring demands methods that can detect it at parts-per-trillion levels, not merely parts per billion.

The analytical challenge is twofold. First, real environmental samples are messy: BPA coexists with phenolic relatives, dissolved organic matter and salts that can swamp a detector. Second, the gold-standard instruments for trace BPA analysis, such as liquid chromatography coupled to mass spectrometry, are expensive, require skilled operators and are often unavailable in the laboratories of developing regions where water quality problems are most acute. Spectrophotometry, by contrast, is cheap, robust and found in nearly every teaching and municipal lab, but on its own it lacks the selectivity and sensitivity to pick a single endocrine disruptor out of a complex matrix. The new study addresses both problems at once by pairing a highly selective extraction material with an affordable optical readout.

The heart of the method is molecular imprinting, sometimes described as building a plastic mold around a molecule. The researchers polymerized functional monomers in the presence of BPA itself, so that as the polymer network hardened, cavities formed that were complementary to the template in size, shape and chemical functionality. After the template was leached out, the polymer was left with recognition sites that preferentially rebind BPA over structurally similar compounds, behaving like artificial antibodies but with far greater chemical and thermal stability. The team chose a core-shell architecture: a solid core provides mechanical integrity and a large surface area, while a thin imprinted shell places the recognition cavities close to the surface, where analyte molecules can reach them quickly rather than diffusing through a dense polymer bulk.

Synthesis proceeded by co-precipitation polymerization, a straightforward route that avoids elaborate equipment and yields particles suitable for packing into extraction cartridges. The material was characterized with Fourier-transform infrared spectroscopy, which confirmed the functional groups responsible for binding, and field-emission scanning electron microscopy, which revealed the morphology of the imprinted particles. UV/Vis spectroscopy served both to track template removal and, ultimately, to quantify BPA after extraction. The simplicity of this characterization and workflow is part of the appeal: the entire pipeline from sample to number can run on instruments that cost a small fraction of a mass spectrometer.

Performance optimization followed the classic levers of adsorption chemistry. The researchers systematically varied pH, contact time, adsorbent dose and shaking speed to maximize uptake. The optimum emerged at pH 6, close to the neutral conditions of most natural waters, which is convenient for direct application to real samples. Under these conditions the polymer reached a maximum adsorption capacity of 112.35 milligrams of BPA per gram of material, a figure that reflects both the density of imprinted cavities and the accessibility afforded by the core-shell geometry. Kinetic analysis showed that adsorption follows a pseudo-second-order model, meaning the rate-limiting step is the chemical interaction between BPA and its binding sites rather than simple diffusion, while equilibrium data fit the Langmuir isotherm, indicating uniform, monolayer-type binding onto a finite set of equivalent sites.

The selectivity results are perhaps the most striking. When the polymer was challenged with coexisting molecules that resemble BPA, the relative selectivity factors came out below one, confirming that the imprinted cavities genuinely discriminate in favor of their template. This matters enormously in practice, because environmental waters contain bisphenol analogs and phenolic compounds whose signals would otherwise interfere. The calibration curve was linear across 2 to 10 micrograms per liter after preconcentration by solid-phase extraction, and the limits of detection and quantification were 0.98 nanograms per liter and 329.5 nanograms per liter respectively. Those numbers mean the method can confidently flag BPA at concentrations relevant to regulatory and toxicological thresholds, using an optical detector rather than a mass spectrometer.

To prove the method works outside the laboratory, the team applied it to real environmental samples, and the technique performed successfully, recovering BPA from the complex matrices that typically defeat less selective adsorbents. The combination of a selective imprinted polymer, a simple solid-phase extraction step and conventional spectrophotometric detection creates a workflow that municipal water utilities, university teaching labs and field stations in resource-limited settings could realistically adopt. It also aligns with a broader movement in separation science toward greener, more affordable analytical chemistry, in which molecularly imprinted materials are increasingly promoted as sustainable alternatives to solvent-intensive extractions and instrument-heavy confirmatory methods.

The work also fits into a fast-growing literature on core-shell imprinted particles, which have been used for everything from extracting BPA from milk to sensing proteins and detecting veterinary drug residues. By keeping the imprinted layer thin, the core-shell design solves the chronic weakness of conventional bulk-imprinted polymers, in which many recognition sites are buried so deep that analytes cannot reach them, wasting capacity and slowing equilibration. The new study demonstrates that a facile co-precipitation synthesis, rather than a complex multistep fabrication, is enough to capture those benefits for environmental monitoring.

For the public, the significance is straightforward: the plastics that make modern life convenient shed a hormone-mimicking chemical into water at concentrations that are difficult to measure but increasingly regulated. Tools like this core-shell imprinted polymer make it possible for far more laboratories to find out exactly how much BPA is in a river, a reservoir or a tap, at a fraction of the usual cost. If such methods spread, the data they generate could sharpen exposure assessments, support enforcement of tightened safety limits, and ultimately push manufacturers toward safer alternatives. The study, published in Polymer Bulletin, shows that sometimes the path to ultrasensitive detection is not a more expensive instrument but a smarter piece of plastic designed to recognize a single molecule.

Subject of Research: Development of a core-shell molecularly imprinted polymer for ultrasensitive solid-phase extraction and spectrophotometric detection of bisphenol-A in environmental samples

Article Title: High-performance core-shell designed molecularly imprinted polymer solid-phase extraction for ultrasensitive spectrophotometric monitoring of bisphenol-A

Article References: Jagirani, M. S., Balouch, A., Jagirani, I., & Khuhawar, A. H. (2026). High-performance core-shell designed molecularly imprinted polymer solid-phase extraction for ultrasensitive spectrophotometric monitoring of bisphenol-A. Polymer Bulletin, 83(11), Article 635. https://doi.org/10.1007/s00289-026-06686-x

Image Credits: AI Generated

DOI: 10.1007/s00289-026-06686-x

Keywords: bisphenol-A, molecularly imprinted polymer, core-shell, solid-phase extraction, spectrophotometry, endocrine disruptor, water analysis, adsorption, Langmuir isotherm, environmental monitoring, co-precipitation polymerization, UV/Vis spectroscopy

The research, conducted by Rachel Giles, Chrisna Durandt, Melvin A. Ambele and Michael S. Pepper at the University of Pretoria, tackles a bottleneck that has long constrained obesity research. Most laboratory models of adipogenesis—the process by which undifferentiated cells mature into lipid-filled fat cells—rely on murine cell lines such as the immortalized 3T3-L1 preadipocyte line derived from mouse embryos. Although these models are well established, human cells offer greater physiological compatibility and relevance to human disease. The South African team therefore turned to adipose-derived stromal/stem cells, or ASCs, which are isolated from adipose tissue and possess a strong natural capacity to differentiate into adipocytes. Because these cells are of human origin, findings obtained with them are more likely to translate reliably into the clinical setting, making them an excellent platform for studying human fat cell formation in a dish.

Adipogenesis itself is a tightly choreographed biological program. Multipotent mesenchymal stromal/stem cells first commit to the preadipocyte lineage and then accumulate intracellular lipid droplets as they mature into adipocytes. Researchers typically quantify this process in two complementary ways: by measuring the accumulation of lipid droplets inside the cells, a morphological hallmark of differentiation, or by tracking the expression of genes associated with adipogenesis. Both approaches have historically been performed in large 6-well or 12-well culture plates, formats that consume substantial quantities of cells, reagents and time. Screening a library of 100 potential anti-obesity compounds in triplicate under such conditions quickly becomes prohibitively expensive, which is precisely the problem the Pretoria group set out to solve by asking whether adipogenic differentiation could be reliably monitored in much smaller wells.

To answer that question, the team isolated ASCs from adipose tissue donated by patients undergoing liposuction, with informed consent and approval from the university’s Research Ethics Committee. The cells were expanded in complete growth medium and characterized by flow cytometry, showing the expected surface marker profile: positive for CD44, CD73 and CD90, and negative for CD34, CD45 and CD105. The absence of CD105 deviates slightly from the minimal criteria recommended by the International Society for Cell and Gene Therapy and the International Federation for Adipose Therapeutics and Science, but the researchers note that CD105 expression is known to vary with culture conditions, and previous work has shown that CD105-negative mesenchymal stromal cells retain full differentiation potential across all three mesodermal lineages. Consistent with that literature, the cells in this study differentiated robustly into adipocytes when induced.

The experimental design was elegantly systematic. ASCs were seeded into 6-, 12-, 24-, 48- and 96-well plates, with plating densities adjusted to each well size, and driven to differentiate over 21 days using a cocktail of adipogenic inducers: the phosphodiesterase inhibitor IBMX, insulin, the cyclooxygenase inhibitor indomethacin and the glucocorticoid dexamethasone. Non-induced cultures served as undifferentiated controls. Lipid accumulation was then assessed on days 0, 14 and 21 using four independent readouts: fluorescence microscopy, flow cytometry, reverse transcription quantitative polymerase chain reaction (RT-qPCR) and spectrophotometry. Under the microscope, induced cultures in every well size displayed cells studded with multiple intracellular lipid droplets stained by the fluorescent dye Nile Red, while non-induced controls showed only low-level background fluorescence attributable to endogenous cellular fluorophores such as flavins and flavoproteins. By day 21, some cells harbored enlarged droplets, hinting at the droplet merging that characterizes fully mature adipocytes in living tissue.

Flow cytometry provided quantitative confirmation. The proportion of Nile Red-positive cells was highest in the standard 6-well format, reaching 41.85 percent on day 14 and 38.38 percent on day 21, but substantial differentiation was also detected in every smaller format, including roughly 30 percent of cells in the 96-well plates. Differences between days 14 and 21 were not statistically significant, and the only significant differences among plate sizes on day 14 were between the 6-well plate and the 24- and 48-well plates. Spectrophotometry, which measures the optical density of the lipid dye Oil Red O extracted from stained cells and normalized to cell count, likewise showed elevated lipid content in induced cultures across all well sizes, with no significant differences between formats on either measurement day. One technical wrinkle emerged: unbound Oil Red O tended to stick to the plastic of smaller wells, inflating optical density readings in non-induced controls as well size decreased.

The gene expression data told a similar story, with an important caveat. Induced cultures upregulated the key adipogenic transcription factors PPARG and CEBPA—PPARγ being the master regulator of fat cell formation—together with the PPARγ-responsive genes CD36 and FABP4, which mark terminally differentiated adipocytes. Expression levels were statistically indistinguishable across the 6-, 12- and 24-well formats. However, the smaller wells yielded too few cells to extract sufficient RNA consistently, forcing the researchers to pool wells for RT-qPCR and leaving the 48- and 96-well gene expression data incomplete. Low RNA yield from the smallest formats thus stands as the principal limitation for transcript-based readouts, and the authors suggest that the RT-qPCR protocol will need optimization for low cell numbers before gene expression can serve as a truly high-throughput endpoint.

To compare the different plate sizes and methods rigorously, the team employed Bland-Altman multiple comparison plots, a statistical technique that assesses agreement between measurement approaches by examining bias and the limits of agreement. Using the 6-well plate as the reference standard, the 24-well format showed the least variability for flow cytometry and for both PPARG and FABP4 gene expression, while the 96-well plate consistently showed the highest variability. When methods were compared against each other with flow cytometry as the reference, spectrophotometry produced the tightest agreement across all well sizes on both days 14 and 21. The overall conclusion was encouraging: all well sizes were broadly comparable, meaning the choice of assay can be guided by reliability and cost rather than by fundamental incompatibility between formats.

Cost analysis drove the practical payoff home. Assuming a standard 21-day induction and including positive, negative and non-induced controls in triplicate, screening 100 compounds by spectrophotometry in 48-well plates would cost approximately R30,998, or about $1,658, making it the cheapest option by a clear margin. Flow cytometry in the same format would cost roughly $2,099, while RT-qPCR in 12-well plates—the smallest format that reliably yielded sufficient mRNA—would run to about $5,223. The researchers conclude that adipogenic differentiation of human ASCs can be quantified with confidence in 24- and 48-well plates, offering a higher-throughput, more time-efficient and more affordable approach than the traditional 6-well standard. Spectrophotometry emerges as an ideal first-pass screen for anti-adipogenic activity, with flow cytometry providing rich single-cell quantification and RT-qPCR illuminating gene-level effects at later stages of a screening pipeline. The critical next step will be validating the platform with established anti-adipogenic compounds such as PPARγ antagonists, a demonstration that would cement the assay’s utility in the hunt for the next generation of obesity therapies.

Subject of Research: Development of a high-throughput in vitro assay for monitoring adipogenesis of human adipose-derived stromal/stem cells for anti-obesity drug screening

Article Title: Development of a high-throughput assay for monitoring adipogenesis in vitro

Article References: Giles, R., Durandt, C., Ambele, M. A., & Pepper, M. S. (2026). Development of a high-throughput assay for monitoring adipogenesis in vitro. Current Research in Biotechnology, Article 100419. https://doi.org/10.1016/j.crbiot.2026.100419

Image Credits: AI Generated

DOI: 10.1016/j.crbiot.2026.100419

Keywords: adipogenesis, obesity, adipose-derived stromal/stem cells, high-throughput screening, flow cytometry, spectrophotometry, RT-qPCR, Nile Red, Oil Red O, PPARG, drug discovery, cell culture

The review’s authors, Ravi Patel of ThermoFisher Scientific, Dipen Purohit of Navinta LLC, and Krupalkumar Morker of Frontage Laboratories, compiled analytical methods published between 2010 and 2025 for the simultaneous estimation of the two antihypertensive agents in pharmaceutical formulations and biological matrices. Their motivation stems from a growing tension in pharmaceutical quality control: the same laboratories that validate drug safety generate streams of toxic solvent waste, consume large amounts of energy, and expose analysts to hazardous chemicals. As sustainability expectations rise across the industry, the environmental footprint of the analytical methods themselves has come under scrutiny alongside the performance metrics that regulators traditionally demand.

The two drugs at the center of the assessment are clinically complementary. Amlodipine besylate is a long-acting dihydropyridine calcium channel blocker that relaxes blood vessels by inhibiting calcium ion influx into vascular smooth muscle and cardiac cells, reducing peripheral resistance and the heart’s oxygen demand. Indapamide, a thiazide-like diuretic, works differently: it blocks sodium reabsorption in the kidney’s distal convoluted tubule, increasing sodium and water excretion and lowering plasma volume, while also exerting vasodilatory effects independent of its diuretic action. Combined in a single pill, the two agents achieve better blood pressure control at lower doses than either drug alone, minimizing side effects and improving patient compliance. Hypertension affects approximately 1.28 billion adults worldwide, and according to the World Health Organization nearly 46 percent of those affected are unaware of their condition, making reliable, affordable quality control for these medicines a genuine global health matter.

To quantify environmental performance, the reviewers applied two complementary scoring systems. The first, the Analytical GREEnness metric, or AGREE, was developed at Gdańsk University of Technology and evaluates a method against the twelve principles of green analytical chemistry. It produces a radial, clock-like diagram in which each segment is color-coded from red, indicating poor greenness, to green, indicating strong performance, and yields a cumulative score from 0 to 1. The second tool, the Analytical Eco-Scale, starts from an ideal score of 100 points and deducts penalty points for hazardous reagents, excessive solvent quantities, high energy consumption, waste generation, and safety risks. Methods scoring 75 or above are classified as excellent green analysis, those between 50 and 75 as acceptable, and anything below 50 as ecologically unacceptable.

The results were strikingly consistent. Spectrophotometric methods, which measure how much ultraviolet or visible light a dissolved drug absorbs, achieved AGREE scores between 0.62 and 0.66 and Eco-Scale scores as high as 97. A first derivative ratio spectrophotometry method topped the ranking with an Eco-Scale score of 97, while absorbance ratio, area under the curve, ultraviolet absorbance correction, and Vierordt’s simultaneous equations methods all clustered around AGREE scores of 0.62 to 0.66 with Eco-Scale values of 91. The reasons are straightforward: these techniques require minimal solvent, typically just methanol, need no buffer solutions, involve little or no sample preparation, consume very little energy, and generate almost no waste. For routine quality control of tablets in resource-conscious settings, the review suggests they remain hard to beat.

High-performance thin-layer chromatography, or HPTLC, produced a more nuanced picture that hinged entirely on solvent choice. A stability-indicating HPTLC method using ethanol, ethyl acetate, and triethylamine achieved the single highest AGREE score of the entire comparison, 0.70, along with an Eco-Scale score of 91, demonstrating that planar chromatography can be genuinely green when built on renewable, low-toxicity solvents. By contrast, a conventional HPTLC method relying on dichloromethane, a hazardous chlorinated solvent, scored only 0.50 on AGREE with an Eco-Scale value of 83. The lesson, the authors argue, is that the same instrumental platform can occupy opposite ends of the sustainability spectrum depending on the chemistry chosen to run it.

Conventional reversed-phase high-performance liquid chromatography, the workhorse of pharmaceutical analysis, fared less well. AGREE scores for RP-HPLC methods ranged from 0.47 to 0.61, with Eco-Scale values between 80 and 87. The environmental burden comes from the technique’s fundamental operating model: continuous pumping of mobile phase through a column at flow rates typically between 0.6 and 1.5 milliliters per minute, using organic solvents such as acetonitrile and methanol mixed with phosphate, acetate, or citrate buffers. Every analysis flushes liters of solvent mixture into waste containers over time, and the pumps and detectors draw continuous power. Methods employing phosphate buffers and triethylamine scored at the lower end of the chromatographic range, while stability-indicating variants with optimized solvent compositions achieved slightly better values.

Yet the review also identified a promising path forward within chromatography itself. An RP-HPLC method developed under Analytical Quality by Design, or AQbD, principles, using a mobile phase of methanol and 0.1 percent orthophosphoric acid at pH 4.5, reached an AGREE score of 0.61 and an Eco-Scale score of 87, among the best chromatographic results. AQbD is a systematic framework that identifies the critical method parameters affecting performance and deliberately optimizes them, and the review shows it can be steered toward environmental goals as well as analytical ones. Similarly, an eco-friendly RP-HPLC method for amlodipine impurity profiling that substituted ethanol for more problematic solvents satisfied both greenness metrics while maintaining full separation of the drug’s known impurities, and an optimized UPLC method for amlodipine recorded a low environmental impact value on the HPLC-EAT scale alongside excellent reproducibility.

At the opposite extreme sat the most technologically advanced approach. UPLC–MS/MS and LC–MS/MS methods, which couple ultra-performance liquid chromatography with tandem mass spectrometry, recorded some of the lowest scores in the assessment, with an AGREE value of 0.47 and an Eco-Scale score of 68. These hyphenated techniques are unmatched for sensitivity and specificity, capable of quantifying amlodipine, indapamide, and other antihypertensives in human serum for therapeutic drug monitoring and bioequivalence studies. But that power carries a cost: high-purity solvents, buffer salts, energy-intensive instrumentation, and complex solvent systems all weigh heavily against them on greenness metrics. The review does not suggest abandoning them, since bioanalytical work in plasma and serum has few alternatives, but it does highlight that their routine use where simpler methods suffice carries a substantial and often unexamined environmental price.

The broader message of the review extends well beyond these two drugs. Current ICH validation guidelines focus on precision, accuracy, and robustness but say little about sustainability, and the authors argue that green chemistry principles should be integrated from the earliest stages of method development rather than assessed as an afterthought. Their recommendations include replacing hazardous solvents with greener alternatives such as ethanol and ethyl acetate, minimizing solvent volumes, adopting AQbD frameworks to optimize flow rates and compositions, and pursuing miniaturization and automation. Spectrophotometric and AQbD-assisted HPTLC approaches, they conclude, offer the best combination of green credentials and analytical reliability for routine pharmaceutical quality control. As regulators and the public increasingly expect the pharmaceutical industry to align with sustainable development goals, the environmental scorecard of the laboratory bench, this review suggests, deserves the same rigor as the assay results it produces.

Subject of Research: Greenness assessment of analytical methods for quantifying amlodipine besylate and indapamide

Article Title: Comparative greenness assessment of analytical methods for the estimation of amlodipine besylate and indapamide using green analytical chemistry principles

Article References: Comparative greenness assessment of analytical methods for the estimation of amlodipine besylate and indapamide using green analytical chemistry principles. (n.d.). https://doi.org/10.1007/s44509-026-00013-3

Image Credits: AI Generated

DOI: 10.1007/s44509-026-00013-3

Keywords: green analytical chemistry, amlodipine besylate, indapamide, AGREE metric, Analytical Eco-Scale, spectrophotometry, RP-HPLC, HPTLC, UPLC-MS/MS, Analytical Quality by Design, pharmaceutical analysis, sustainability

The research team, led by Vijayapandi Pandy of MIT World Peace University in Pune and colleagues at Chalapathi Institute of Pharmaceutical Sciences in Guntur, India, adapted a spectrophotometric method originally developed in 2009 for detecting dopamine in pharmaceutical products, serum, urine, and even bananas. Their innovation lies not in inventing new chemistry but in extending an established, inexpensive technique into the far messier world of biological brain tissue. The work was conceived explicitly for resource-constrained settings, where advanced analytical instruments are unavailable and where the cost barrier of conventional neurochemical assays effectively excludes entire research communities from dopaminergic research.

The chemistry underpinning the assay is elegantly straightforward. Dopamine, chemically known as 4-(2-aminoethyl) benzene-1,2-diol, belongs to the catecholamine family and possesses a catechol structure with notable reducing power. When brain tissue homogenate is mixed with ferric chloride, dopamine acts as a reducing agent, converting ferric iron, Fe(III), into ferrous iron, Fe(II). These freshly generated ferrous ions then react with potassium ferricyanide to form a stable, soluble Prussian blue complex, formally written as KFe(III)[Fe(II)(CN)6]. This deep blue compound absorbs light maximally at a wavelength of 735 nanometers, a region of the spectrum where interference from other endogenous organic molecules in complex tissue extracts is minimal. That spectral selectivity is what makes the method viable for biological matrices rather than only clean pharmaceutical solutions.

To establish the analytical foundation, the researchers prepared a primary stock solution of dopamine hydrochloride at 1000 micrograms per milliliter and generated a series of standard solutions spanning concentrations from 0.1 to 10 micrograms per milliliter. When the absorbance of each standard was measured at 735 nanometers, the resulting calibration curve displayed a robust linear relationship, described by the regression equation Y = 0.08807X + 0.02025 with a coefficient of determination of 0.9760. This linearity, which slightly extends the range reported in the original pharmaceutical assay, indicates that Prussian blue formation follows Beer-Lambert’s law across the working range and that the buffered brain homogenate environment provides a stable medium for the color reaction. The 95 percent confidence intervals for the slope and intercept were narrow enough to support quantitative use in preliminary screening applications.

The biological validation drew on three remarkably different species. Chicken heads were obtained from a licensed slaughterhouse and fish heads, from the species Labeo rohita, came from a local market, while a single male Swiss albino mouse served as the mammalian reference tissue. All tissue was kept ice-cold during transport and dissection to prevent proteolytic degradation of neurotransmitters. Whole brains were homogenized in 0.1 M phosphate buffer at pH 7.4 using a standardized ratio of one gram of tissue per twenty milliliters of buffer, then centrifuged at 2000 revolutions per minute for ten minutes at five degrees Celsius. The resulting supernatants were diluted to 10, 25, 50, and 75 percent working concentrations, and each aliquot was reacted with potassium ferricyanide and ferric chloride for thirty-five minutes at room temperature before absorbance was read against a reagent blank on a standard laboratory spectrophotometer.

The results revealed striking interspecies differences in brain dopamine content. Mouse brain tissue contained the highest concentration, corresponding to 479.3 micrograms of free dopamine per gram of tissue, equivalent to 593.2 micrograms per gram when expressed as dopamine hydrochloride. Fish brain followed with 325.9 micrograms of free dopamine per gram, or 403.4 micrograms per gram as the hydrochloride salt. Chicken brain showed the lowest concentration at 77.4 micrograms of free dopamine per gram, or 95.8 micrograms per gram as dopamine hydrochloride. The authors attribute these differences to the varying densities of dopaminergic neurons and distinct metabolic rates inherent to murine, piscine, and avian central nervous systems, and they note that the values fall within ranges reported in previous studies, though direct comparison with region-specific or chromatographic measurements should be interpreted with caution.

Beyond the analytical numbers, the study carries a quiet but significant ethical dimension. Because chicken and fish brains are readily available as post-mortem byproducts from slaughterhouses and markets, they require no institutional animal ethics approval under Indian CCSEA guidelines. The researchers explicitly propose these tissues as practical substitutes for laboratory rodents during the preliminary stages of method development, optimization, and proof-of-concept experiments. By reducing the number of animals used for teaching, method development, and training, the approach aligns with the 3Rs concept, the internationally recognized framework calling for replacement, reduction, and refinement in animal research. The single mouse used in the study was euthanized by cervical dislocation without anesthetic agents, a deliberate choice to avoid confounding effects of anesthetics on monoaminergic neurotransmission, and the procedure was conducted under an approved institutional ethics protocol.

The authors are candid about the limitations of their preliminary proof-of-concept design. Calibration points were established using single measurements rather than replicates, and comprehensive evaluation of matrix effects, including recovery studies and interference from endogenous biomolecules, was beyond the scope of the present investigation. They also acknowledge that centrifugation at higher speeds, around 10,000 revolutions per minute for twenty minutes at four degrees Celsius, would likely remove more cellular debris and insoluble proteins, reducing matrix interference and improving accuracy. Future studies, they state, will include full analytical validation with triplicate calibration measurements in accordance with internationally accepted guidelines such as ICH Q2(R2) and USP General Chapter 1225, establishing precision, accuracy, linearity, repeatability, and overall reliability, alongside direct comparison with established techniques like high-performance liquid chromatography.

Even with those caveats, the significance of the work lies in its accessibility. A UV-visible spectrophotometer is among the most common instruments found in laboratories worldwide, and the reagents required, potassium ferricyanide and ferric chloride, are inexpensive, stable, and easy to prepare. The assay requires no complex sample preparation, delivers rapid results, and can process multiple dilutions of tissue homogenates with consistent outcomes. For neuropharmacology laboratories evaluating dopaminergic activity in animal models of neurological disorders, particularly in low-resource settings where advanced analytical instruments are unavailable, the method offers a critical balance of simplicity and sensitivity. The researchers suggest it is highly suitable for routine laboratory estimations of dopamine and for preliminary neurochemical screening before committing samples to more sophisticated and costly confirmatory analyses.

The broader implications extend to how science is done, not just what it discovers. As dopamine research continues to drive progress on Parkinson’s disease, schizophrenia, substance use disorders, and the neurobiology of motivation and reward, the bottleneck has often been not ideas but infrastructure. By demonstrating that a century-old iron chemistry reaction can quantify a key neurotransmitter across mammalian, avian, and piscine brain tissues with a simple benchtop instrument, this study lowers the entry barrier for a global community of researchers and educators. If subsequent validation confirms its robustness in complex biological matrices, the humble Prussian blue assay may become a standard first step in neurochemical laboratories that could never otherwise afford to look inside the dopaminergic brain.

Subject of Research: A cost-effective UV spectrophotometric method for quantifying dopamine in avian, piscine, and murine brain tissues

Article Title: A cost-effective UV spectrophotometric method for dopamine estimation in avian, piscine, and murine brain tissues

Article References: Pandy, V., Vanjarapu, H. D., Polimera, C. S., Dukkipati, S., & Thakre, K. (2026). A cost-effective UV spectrophotometric method for dopamine estimation in avian, piscine, and murine brain tissues. Discover Chemistry, 3(1), Article 526. https://doi.org/10.1007/s44371-026-00995-w

Image Credits: AI Generated

DOI: 10.1007/s44371-026-00995-w

Keywords: dopamine, UV spectrophotometry, Prussian blue, potassium ferricyanide, neurochemistry, brain tissue, spectrophotometry, neuropharmacology, catecholamines, low-cost analytical methods, 3Rs principle, animal models